Recombinant Human Endostatin Suppressed the Biological Behavior of Human Umbilical Vein Endothelial Cells Under Hypoxic and Hypoxic/Starvation Conditions In Vitro
Recombinant human endostatin (rh-endostatin) has been shown to act as an inhibitor of angiogenesis. Previous studies have indicated that rh-endostatin combined with chemotherapy can improve the objective response rate (ORR), time to progression (TTP), and clinical benefit rate (CBR) without increasi...
Saved in:
| Main Authors: | Yongsheng Jia, Cuicui Zhang, Jimin Zhao, Chuanxiang Hu, Xiaoyong Yang, Yan Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Analytical Cellular Pathology |
| Online Access: | http://dx.doi.org/10.1155/ancp/3475731 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Isolation and study of bioactivities study of the recombinant human endostatin
by: E. S. Kalinina, et al.
Published: (2006-02-01) -
Uric Acid Promotes Human Umbilical Vein Endothelial Cell Senescence In Vitro
by: Katarzyna Lewandowska, et al.
Published: (2025-06-01) -
Anti-Inflammatory Properties of Sirtuin 6 in Human Umbilical Vein Endothelial Cells
by: Martha Lappas
Published: (2012-01-01) -
Propofol attenuates the adhesion of tumor and endothelial cells through inhibiting glycolysis in human umbilical vein endothelial cells
by: Qi Jie, et al.
Published: (2019-10-01) -
Effects of Nebivolol on Endothelial Gene Expression during Oxidative Stress in Human Umbilical Vein Endothelial Cells
by: Ulisse Garbin, et al.
Published: (2008-01-01)